Correction to: Heregulin ?1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Hutcheson, Iain R.; Knowlden, Janice M.; Hiscox, Steve E.; Barrow, Denise; Gee, Julia M. W.; Robertson, John F.; Ellis, Ian O.; Nicholson, Robert I.

Abstract

© 2018 The Author(s). After the publication of this work [1], an error was noticed in Fig. 2b and Fig. 4b as well as Fig. 4b. and Fig. 5d. Images of the ERK1/2 blots were accidentally duplicated. In Fig. 5a. and Fig. 5c., the last lane for p-ERK1/2 was mistakenly cropped out of the final image. The original blot for Fig. 4b., "total EGFR" (or lane 2) is shown below to avoid any misunderstanding of the data. We apologize for this error, which did not affect any of the interpretations or conclusions of the article.

Citation

Hutcheson, I. R., Knowlden, J. M., Hiscox, S. E., Barrow, D., Gee, J. M. W., Robertson, J. F., …Nicholson, R. I. (2018). Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells. Breast Cancer Research, 20, Article 98 (2018). https://doi.org/10.1186/s13058-018-0999-6

• Journal Article Type: Article
• Acceptance Date: Jun 6, 2018
• Online Publication Date: Aug 30, 2018
• Publication Date: Aug 30, 2018
• Deposit Date: Aug 8, 2019
• Publicly Available Date: Aug 8, 2019
• Journal: Breast Cancer Research
• Print ISSN: 1465-5411
• Electronic ISSN: 1465-542X
• Publisher: Springer Verlag
• Peer Reviewed: Peer Reviewed
• Volume: 20
• Article Number: 98 (2018)
• DOI: https://doi.org/10.1186/s13058-018-0999-6
• Public URL: https://nottingham-repository.worktribe.com/output/2406682
• Publisher URL: https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-0999-6